The Conversation (0)
ABBVie (NYSE: ABBV) will participate in Bernstein's 37 th Annual Strategic Decisions Conference on Wednesday, June 2, 2021 . Michael Severino M.D., vice chairman and president, and Robert A. Michael executive vice president and chief financial officer, will present virtually at 2:30 p.m. Central time .
A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.
About AbbVie Â
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on Twitter , Facebook , Instagram , YouTube and LinkedIn .
View original content: https://www.prnewswire.com/news-releases/abbvie-to-present-at-bernsteins-37th-annual-strategic-decisions-conference-301299171.html
SOURCE AbbVie
